Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies

被引：24

作者：

Farley, TMM ^{[1
]}

Meirik, O ^{[1
]}

Poulter, NR ^{[1
]}

Chang, CL ^{[1
]}

Marmot, MG ^{[1
]}

机构：

[1] UCL, SCH MED, DEPT EPIDEMIOL & PUBL HLTH, LONDON W1N 8AA, ENGLAND

来源：

CONTRACEPTION | 1996年 / 54卷 / 03期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1016/S0010-7824(96)00166-7

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：193 / 195

页数：3

共 11 条

[1]

Bloemenkamp K, 1996, GYNECOL ENDOCRINOL, V10, P1

[2] ENHANCEMENT BY FACTOR-V LEIDEN MUTATION OF RISK OF DEEP-VEIN THROMBOSIS ASSOCIATED WITH ORAL-CONTRACEPTIVES CONTAINING 3RD-GENERATION PROGESTAGEN [J].

BLOEMENKAMP, KWM ;

ROSENDAAL, FR ;

HELMERHORST, FM ;

BULLER, HR ;

VANDENBROUCKE, JP .

LANCET, 1995, 346 (8990) :1593-1596

[3]

FARLEY TMM, 1995, LANCET, V346, P1582

[4]

Farmer R, 1996, LANCET, V347, P259

[5] RISK OF IDIOPATHIC CARDIOVASCULAR DEATH AND NONFATAL VENOUS THROMBOEMBOLISM IN WOMEN USING ORAL-CONTRACEPTIVES WITH DIFFERING PROGESTAGEN COMPONENTS [J].

JICK, H ;

JICK, SS ;

GUREWICH, V ;

MYERS, MW ;

VASILAKIS, C .

LANCET, 1995, 346 (8990) :1589-1593

[6]

Lewis MA, 1996, BRIT MED J, V312, P88

[7] Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies [J].

Lidegaard, O ;

Milsom, I .

CONTRACEPTION, 1996, 53 (03) :135-139

[8]

Poulter NR, 1996, LANCET, V347, P547

[9]

SPEROFF L, 1993, OBSTET GYNECOL, V81, P1034

[10]

Spitzer WO, 1996, BRIT MED J, V312, P83

← 1 2 →